Alpha-Proteinase Inhibitors

Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy

Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy Their primary therapeutic role is to elevate and replenish circulating serum and alveolar levels of functional alpha1-antitrypsin, which directly neutralizes neutrophil elastase to prevent proteolytic degradation of pulmonary elastin Consequently, this therapeuti...

Alpha-proteinase inhibitors, more formally designated by the FDA as alpha1-proteinase inhibitor (human) biologics or blood derivatives, are plasma-purified serine protease inhibitors used for chronic augmentation and maintenance therapy Their primary therapeutic role is to elevate and replenish circulating serum and alveolar levels of functional alpha1-antitrypsin, which directly neutralizes neutrophil elastase to prevent proteolytic degradation of pulmonary elastin

Their primary therapeutic role is to elevate and replenish circulating serum and alveolar levels of functional alpha1-antitrypsin, which directly neutralizes neutrophil elastase to prevent proteolytic degradation of pulmonary elastin

Consequently, this therapeutic class is indicated specifically for adults with congenital alpha-1 antitrypsin deficiency who exhibit clinically evident panacinar emphysema, helping to slow the acceleration of lung tissue destruction